These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 37461336)
1. Amyloid peptide hydrogels Wang Q; Zhou FP; Tao DD; Wei JH; Cai R; Jiang YB Chem Commun (Camb); 2023 Aug; 59(63):9599-9602. PubMed ID: 37461336 [TBL] [Abstract][Full Text] [Related]
2. Depletion of amyloid-β peptides from solution by sequestration within fibril-seeded hydrogels. Yau WM; Tycko R Protein Sci; 2018 Jul; 27(7):1218-1230. PubMed ID: 29417648 [TBL] [Abstract][Full Text] [Related]
3. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. Tjernberg LO; Näslund J; Lindqvist F; Johansson J; Karlström AR; Thyberg J; Terenius L; Nordstedt C J Biol Chem; 1996 Apr; 271(15):8545-8. PubMed ID: 8621479 [TBL] [Abstract][Full Text] [Related]
4. The effect of terminal groups and halogenation of KLVFF peptide on its activity as an inhibitor of β-amyloid aggregation. Khalili Samani E; Mofid MR; Malakoutikhah M J Pept Sci; 2020 Feb; 26(2):e3227. PubMed ID: 31845472 [TBL] [Abstract][Full Text] [Related]
5. Amyloid Beta Peptide VHHQ, KLVFF, and IIGLMVGGVV Domains Involved in Fibrilization: AFM and Electrochemical Characterization. Enache TA; Chiorcea-Paquim AM; Oliveira-Brett AM Anal Chem; 2018 Feb; 90(3):2285-2292. PubMed ID: 29314823 [TBL] [Abstract][Full Text] [Related]
6. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif. Kino R; Araya T; Arai T; Sohma Y; Kanai M Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033 [TBL] [Abstract][Full Text] [Related]
7. Functionalization of gold nanoparticles with amino acid, beta-amyloid peptides and fragment. Majzik A; Fülöp L; Csapó E; Bogár F; Martinek T; Penke B; Bíró G; Dékány I Colloids Surf B Biointerfaces; 2010 Nov; 81(1):235-41. PubMed ID: 20674288 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro. Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336 [TBL] [Abstract][Full Text] [Related]
10. Peptide backbone modification in the bend region of amyloid-β inhibits fibrillogenesis but not oligomer formation. Johnson EC; Lanning JD; Meredith SC J Pept Sci; 2016 May; 22(5):368-73. PubMed ID: 27114096 [TBL] [Abstract][Full Text] [Related]
16. Beta2-microglobulin amyloid fragment organization and morphology and its comparison to Abeta suggests that amyloid aggregation pathways are sequence specific. Zheng J; Jang H; Nussinov R Biochemistry; 2008 Feb; 47(8):2497-509. PubMed ID: 18215070 [TBL] [Abstract][Full Text] [Related]